Skip to content

PUMA BIOTECHNOLOGY INC

PBYI

Latest QuantConomy context for PBYI: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
17
Asset profile

PUMA BIOTECHNOLOGY INC

QuantConomy has a structured record for PBYI. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
PBYI
Name
PUMA BIOTECHNOLOGY INC
Coverage
3 market/data records
Sources
fmp alphavantage alpaca sec nasdaq openfigi
Latest signal rows

Recent signals for PBYI

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
earnings
earnings release
neutral
40
Feb 26, 12:00 AM PBYI filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
corporate event
other event
neutral
40
Jun 16, 08:10 PM PBYI filed 8-K: Shareholder Vote Results - [weak neutral signal]
corporate event
earnings
neutral
75
May 7, 08:35 PM PBYI filed 8-K: Earnings Release - 1 material event - [strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market coverage

Market Exchange Source Asset record
PBYI NASDAQ fmp Puma Biotechnology, Inc.
PBYI NASDAQ alphavantage Puma Biotechnology Inc
PBYI NASDAQ alpaca Puma Biotechnology Inc Common Stock

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
3
Rows
17
Date Insider Role Type Shares Price Value Filing
Jul 6, 2026 AUERBACH ALAN H President and CEO sale 44,058 $8.26 $364,051 4 on EDGAR
Jul 6, 2026 NOUGUES MAXIMO F Chief Financial Officer sale 9,386 $8.26 $77,557 4 on EDGAR
Jul 6, 2026 HUNT DOUGLAS M See Remarks sale 8,460 $8.26 $69,905 4 on EDGAR
Jun 11, 2026 WILSON TROY EDWARD Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 Dorval Allison Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 Cesano Alessandra Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 Senderowicz Adrian Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 MILLER MICHAEL PATRICK Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 Stuglik Brian M Insider grant 27,000 $0.00 $0 4 on EDGAR
Jun 11, 2026 MOYES JAY M Insider grant 27,000 $0.00 $0 4 on EDGAR
Feb 18, 2026 NOUGUES MAXIMO F Chief Financial Officer grant 46,739 $0.00 $0 4 on EDGAR
Feb 18, 2026 AUERBACH ALAN H President and CEO grant 159,778 $0.00 $0 4 on EDGAR
Feb 18, 2026 HUNT DOUGLAS M See Remarks grant 49,394 $0.00 $0 4 on EDGAR
Jan 6, 2026 HUNT DOUGLAS M See Remarks sale 3,973 $5.84 $23,218 4 on EDGAR
Jan 6, 2026 AUERBACH ALAN H President and CEO sale 16,938 $5.84 $98,986 4 on EDGAR
Jan 6, 2026 NOUGUES MAXIMO F Chief Financial Officer sale 4,540 $5.84 $26,532 4 on EDGAR
Nov 11, 2025 MILLER MICHAEL PATRICK Insider sale 20,000 $4.86 $97,228 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query PBYI context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access